Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Goodyear Indonesia Tbk. (GDYR) vs Merck Tbk. (MERK) Price & Performance

Goodyear Indonesia Tbk.Trade
Merck Tbk.Trade

Price performance (Past 24H)

Key statistics

Goodyear Indonesia Tbk. vs Merck Tbk. — how do they compare? Goodyear Indonesia Tbk. trades at Rp1,080 (market cap 442.8B), while Merck Tbk. trades at Rp3,840 (market cap 1.7T, 500 24h volume). The key difference: Merck Tbk. is far larger — about 3.8× Goodyear Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.

GDYRMERK
Market Cap
442.8B1.7T
Volume
500
Lot
5
Turnover
1.92M
Average Price
3,842
Value
1.92M
Indicative Equilibrium Price
3,850
Indicative Equilibrium Volume
1

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

GDYR
View details
MERK
View details

About Goodyear Indonesia Tbk.

PT Goodyear Indonesia Tbk (the Company) was established on January 6, 1917 under the name “NV The Goodyear Tire & Rubber Company Limited” and changed its name to “PT Goodyear Indonesia” on July 25, 1978. On November 10, 1980, the Company obtained approval from the Capital Market Supervisory Board (BAPEPAM) to offer a portion of its shares to the public through the Indonesia Stock Exchange. Effective December 22, 1980, 6,150,000 shares of the Company with total par value of Rp 6,150,000 (equivalent to 15% of the total issued and outstanding shares) were officially listed in Jakarta Stock Exchange.

Read more on GDYR

About Merck Tbk.

PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.

Read more on MERK